FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

SterRx Sodium Bicarbonate in 5% Dextrose Injection Recall

Sodium Bicarbonate in 5% Dextrose Injection, 150 mEq per 1,000 mL (12

SterRx, LLC · Plattsburgh, NY

Risk level
Class II
Reported by FDA
Sep 1, 2021
Recall ID
D-0768-2021
Check your lot numberHow we source this data

Summary

SterRx recalled Sodium Bicarbonate in 5% Dextrose Injection starting Aug 10, 2021. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0768-2021 on Sep 1, 2021. Reason: Lack of Assurance of Sterility. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility

Product description

Sodium Bicarbonate in 5% Dextrose Injection, 150 mEq per 1,000 mL (12.6 mg per mL), 1,000 mL bags, Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903

Lot numbers, UPCs & expiration codes

Lot Numbers: BTW, exp. date 03/08/22 BUI, exp. date 03/16/22

Where it was sold

Nationwide in the US

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0768-2021
Classification
Class II
Status
Terminated
Recall initiated
Aug 10, 2021
FDA report date
Sep 1, 2021
Quantity
3378 bags
Recall type
Voluntary: Firm initiated
Recalling firm
SterRx, LLC

Original FDA data

Every field from FDA enforcement report D-0768-2021, exactly as published.

Show all FDA fields
City
Plattsburgh
State
NY
Status
Terminated
Country
United States
Event ID
88436
Address
141 Idaho Ave
Code information
Lot Numbers: BTW, exp. date 03/08/22 BUI, exp. date 03/16/22
Postal code
12903-3987
Report date
Sep 1, 2021
Product type
Drugs
Recall number
D-0768-2021
Classification
Class II
Recalling firm
SterRx, LLC
Product quantity
3378 bags
Termination date
May 19, 2022
Reason for recall
Lack of Assurance of Sterility
Voluntary / mandated
Voluntary: Firm initiated
Product description
Sodium Bicarbonate in 5% Dextrose Injection, 150 mEq per 1,000 mL (12.6 mg per mL), 1,000 mL bags, Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903
Distribution pattern
Nationwide in the US
Recall initiation date
Aug 10, 2021
Initial firm notification
Press Release
Center classification date
Aug 25, 2021

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0768-2021, published Sep 1, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls